C

Cellectis SA
D

CLLS

3.49000
USD
0.14
(4.18%)
مغلق
حجم التداول
524
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
350,135,049
أصول ذات صلة الأخبار المقالات

العنوان: Cellectis SA

القطاع: Healthcare
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.